Pharmacy World and Science

Subjective outcome measurement_a primer
pp. 101-109(9)
Authors: Tully M.P.; Cantrill J.A.

Academic detailing improves identification and reporting of adverse drug events
pp. 110-115(6)
Authors: Schlienger R.G.; Lüscher T.F.; Haefeli W.E.; Schoenenberger R.A.

Asthma exacerbations during first therapy with long acting 2-agonists
pp. 116-119(4)
Authors: Gerrits C.M.J.M.; Herings R.M.C.; Leufkens H.G.M.; Lammers J-W.J.

The quality of Dutch hospital drug formularies: Evaluation of technical features and organisational information
pp. 120-126(7)
Authors: Fijn R.; Engels S.A.G.; de Jong-van den Berg L.T.W.; De Vries C.S.; Brouwers J.R.B.J.; De Blaey C.J.

Technicians or patient advocates? - still a valid question
pp. 127-131(5)
Authors: Almarsdttir A.B.; Morgall J.M.

Antidepressant drug choice for first users in two regions in the Netherlands
pp. 132-136(5)
Authors: Egberts A.C.G.; Veenstra M.; de Jong - van den Berg L.T.W.

Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers
pp. 137-141(5)
Authors: Thiesen J.; Krämer I.

The role of the French community pharmacist in drug dispensing
pp. 142-143(2)
Authors: Ghamba G.; Bauguil G.; Gallezot J.

Long-term stability of morphine and bupivacaine mixture for spinal use
pp. 144-146(3)
Authors: Essink-Tjebbes C.M.; Burger D.M.; Beelen M.; Wuis E.W.; Hekster Y.A.

Proceedings – ESCP27 th European Symposium on Clinical Pharmacy Evidence-Based Pharmaceutical Care, 26-28 October 1998, Jerusalem, Israel
pp. 147-166(20)